Cargando…
Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects
The efficacy of using fasting plasma glucose (FPG) alone as a preferred screening test for diabetes has been questioned. This study was aimed to evaluate whether the use of serum advanced glycation end products-peptides (sAGEP) would help to improve the efficacy of FPG in diabetes screening among hi...
Autores principales: | Sun, Zilin, He, Jiajia, Qiu, Shanhu, Lei, Chenghao, Zhou, Yi, Xie, Zuolin, Zhang, Lin, Wang, Yanping, Jin, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569373/ https://www.ncbi.nlm.nih.gov/pubmed/26368827 http://dx.doi.org/10.1371/journal.pone.0137756 |
Ejemplares similares
-
Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
por: Yin, Raynold V, et al.
Publicado: (2015) -
Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016) -
Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration
por: Karnchanasorn, Rudruidee, et al.
Publicado: (2016) -
Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study
por: Teichert, Tom, et al.
Publicado: (2015) -
The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension
por: Geva, Mika, et al.
Publicado: (2019)